GHIT has financed the Pediatric Praziquantel Consortium’s development of arpraziquantel since 2013, investing 1.85 billion yen TOKYO, Dec. 18, 2023 /PRNewswire/ — The Global Health Innovative Technology (GHIT) Fund has supported the Pediatric Praziquantel Consortium’s development of…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.